The nurse would expect to find which signs and symptoms of hypoxia? Select all that apply.

Choice A rationale

A pneumothorax involves the presence of air in the pleural space, leading to a collapsed lung. While it can cause respiratory distress and agitation, it usually presents with sudden, sharp chest pain and absent breath sounds on the affected side. Confusion can occur if the pneumothorax leads to severe respiratory failure, but it is not the most direct or common complication of oxygen therapy in a chronic obstructive pulmonary disease patient compared to other metabolic changes.

Choice B rationale

Hemothorax is the accumulation of blood in the pleural cavity, often resulting from trauma, surgery, or malignancy. It would present with signs of hypovolemia and decreased breath sounds. While it impairs gas exchange, it is an unlikely diagnosis for a patient receiving routine oxygen therapy for chronic obstructive pulmonary disease unless there was a specific acute injury or underlying pathology. It does not directly relate to the physiologic response of oxygen administration in this population.

Choice C rationale

In chronic obstructive pulmonary disease, the respiratory drive may become dependent on low oxygen levels or a hypoxic drive rather than high carbon dioxide levels. Providing continuous oxygen can sometimes suppress this drive, leading to carbon dioxide retention and narcosis, or the oxygen itself may not be sufficient if the patient's condition is worsening. Confusion is a hallmark sign of hypoxia, indicating that the brain is not receiving adequate oxygenation, which is a common and dangerous complication in these patients.

Choice D rationale

A pulmonary embolism occurs when a blood clot blocks a pulmonary artery, causing a sudden mismatch in ventilation and perfusion. While this can cause confusion due to a sudden drop in oxygen saturation, it is usually accompanied by acute chest pain, tachycardia, and hemoptysis. While a risk for any chronic patient, confusion in the context of continuous oxygen therapy for chronic obstructive pulmonary disease is more traditionally and frequently associated with the progression of hypoxia or hypercapnia.

Choice A rationale

Tiotropium is not a corticosteroid and does not primarily function to reduce systemic or local airway inflammation. Corticosteroids like fluticasone are used for this purpose by inhibiting the release of inflammatory mediators and decreasing capillary permeability. Tiotropium is a long-acting muscarinic antagonist that focuses on the mechanical relaxation of smooth muscles rather than the underlying inflammatory cascade seen in chronic obstructive pulmonary disease or asthma. Therefore, this statement inaccurately describes its mechanism.

Choice B rationale

This medication is not a rescue inhaler and should never be used to treat acute bronchospasm or sudden shortness of breath. Short-acting beta-agonists like albuterol are indicated for immediate relief because they work rapidly. Tiotropium has a slow onset of action and is used for maintenance therapy to provide stable bronchodilation over a twenty-four hour period. Using it during an acute attack would be ineffective and potentially dangerous due to the delayed clinical response.

Choice C rationale

Tiotropium works by inhibiting M3 muscarinic receptors in the bronchial smooth muscles. By blocking the action of acetylcholine, it prevents the activation of the parasympathetic nervous system which otherwise causes bronchoconstriction. This leads to prolonged bronchodilation, which helps keep the airways open in clients with advanced chronic obstructive pulmonary disease. This mechanism reduces the resistance to airflow and helps alleviate symptoms like dyspnea and exercise intolerance by preventing the smooth muscles from tightening.

Choice D rationale

While managing secretions is important in chronic obstructive pulmonary disease, tiotropium does not possess mucolytic properties. It does not thin the viscosity of mucus or increase the effectiveness of the cough reflex. In fact, because it is an anticholinergic, it may actually cause a drying effect on the mucous membranes, leading to xerostomia or thickened secretions in some cases. Mucolytics such as acetylcysteine or guaifenesin are specifically designed to address the issues of thick pulmonary mucus.